Sanofi reports $534M in U.S. equity holdings
Sanofi, as an institutional investment manager, reports its quarterly equity holdings under Form 13F. The report is filed as a 13F Holdings Report, meaning all of Sanofi’s reportable U.S.-listed positions are included in this submission.
Rhea-AI Filing Summary
Sanofi, as an institutional investment manager, reports its quarterly equity holdings under Form 13F. The report is filed as a 13F Holdings Report, meaning all of Sanofi’s reportable U.S.-listed positions are included in this submission.
The filing lists 10 reportable positions in the Form 13F Information Table, with an aggregate reported value of $534,041,662 (rounded to the nearest dollar). No other investment managers are included, and Sanofi’s Head of Legal Corporate & Finance, Alexandra Roger, signs on behalf of the reporting manager.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Form 13F regulatory
13F Holdings Report regulatory
Institutional investment manager regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is Sanofi (SNY) reporting in this Form 13F filing?
How many securities does Sanofi (SNY) list in its latest Form 13F?
What is the total reported value of Sanofi’s (SNY) 13F portfolio?
Is this Sanofi (SNY) Form 13F a full holdings report or a notice?
Does Sanofi (SNY) report any other included managers in this Form 13F?
Who signed the Sanofi (SNY) Form 13F and in what capacity?
AI-generated analysis. How Rhea-AI works. Not financial advice.